Data as of Dec 18
| +0.80 / +1.71%|
The 15 analysts offering 12-month price forecasts for NuVasive Inc have a median target of 49.00, with a high estimate of 55.00 and a low estimate of 42.00. The median estimate represents a +2.73% increase from the last price of 47.70.
The current consensus among 20 polled investment analysts is to Buy stock in NuVasive Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.